Xentria Pipeline

Developing the future of novel biologics and biosimilars is
Xentria’s mission in the pharmaceutical industry.

Building the future in biologics

Leveraging our experience and our passion about providing effective therapies, we are building a pipeline of products focused on addressing patient need in the following disease states:

  • Immunology
  • Metabolic Disease
  • Musculoskeletal Disease
  • Oncology
  • Rare Disease

Clinical Development Pipeline


  • R&D
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Contact Us

We would love to hear from you!

Address: 8700 W. Bryn Mawr, Suite 600S, Chicago, IL 60631

Phone: (224) 443 4615

Contact: Contact